- Home
- Supplements
- Citicoline (CDP-Choline)
- Synaptic Plasticity
Citicoline (CDP-Choline) for Synaptic Plasticity
Citicoline supports membrane phospholipid synthesis with modest cognitive trial support.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 250-500mg/day
- Expected timeframe
- 8-12 weeks
Protocol
- studied dose
- 250-500 mg/day, with higher doses used in post-stroke rehabilitation research
- evidence note
- Verdict is insufficient - plasticity-specific endpoints were never directly measured
- what happened
- Randomised trials show improved attention and memory measures in older adults and after stroke, but synaptic plasticity itself was not assessed. The mechanism - supplying cytidine and choline for membrane phospholipid synthesis - is plausible and remains unproven as a human outcome
- if you still trial it
- 250-500 mg each morning with food alongside a structured learning or rehabilitation programme
- what genuinely drives synaptic change
- Repeated skill practice, aerobic exercise and deep sleep
Evidence
What the studies say
Citicoline and membrane phospholipid synthesis in the human brain: a review
Wurtman RJ, Cansev M, Ulus IH
Citicoline increased brain phosphatide levels and dendritic spine density
Safety
Caveats
Cognitive benefits are modest and clearest in impaired populations.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.